Kevin J. Yeaman - 12 Oct 2021 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
Issuer symbol
DLB
Transactions as of
12 Oct 2021
Net transactions value
-$1,395,219
Form type
4
Filing time
13 Oct 2021, 18:57:38 UTC
Previous filing
16 Sep 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $550,166 +14,730 +45% $37.35 47,625 12 Oct 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
transaction DLB Class A Common Stock Sale $1,289,695 -14,730 -31% $87.56 32,895 12 Oct 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F1
transaction DLB Class A Common Stock Options Exercise $632,966 +14,727 +45% $42.98 47,622 12 Oct 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
transaction DLB Class A Common Stock Sale $1,288,655 -14,727 -31% $87.50 32,895 12 Oct 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F2
holding DLB Class A Common Stock 106,414 12 Oct 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -14,730 -100% $0.000000* 0 12 Oct 2021 Class A Common Stock 14,730 $37.35 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F4
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -14,727 -5.1% $0.000000 276,871 12 Oct 2021 Class A Common Stock 14,727 $42.98 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple transactions at prices ranging from $87.13 to $87.905, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 The shares were sold in multiple transactions at prices ranging from $87.13 to $87.905 inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Shares held following the reported transactions include 106,414 restricted stock units, which are subject to forfeiture until they vest.
F4 This option was granted for a total of 287,265 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
F5 This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.

Remarks:

**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**